bullish

Para IV Winners & Losers - May 2018

114 Views07 Jun 2018 21:45
This month’s Para IV developments suggest that there is likely to be benefit to Amneal Pharmaceuticals Inc (AMRX US) on Lialda, BioQ pharma for...
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 22-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Nimish Mehta
Pharma Global
Research Delta Advisors
IndiaHealth CareEquities
  • Para IV Winners & Losers - May 2018
    07 Jun 2018
x